Amikacin is an aminoglycoside antibiotic used to treat serious infections caused by multidrug-resistant Gram-negative bacteria. It works by inhibiting protein synthesis in bacteria. Common indications include suspected or proven late-onset neonatal sepsis and infections caused by susceptible Gram-negative organisms resistant to other antibiotics. Side effects include kidney damage, hearing loss, numbness, tingling, muscle twitching or seizures. Nurses should assess for signs of infection, ensure proper hydration, instruct patients on completing the full course of medication and reporting side effects.
Amikacin is an aminoglycoside antibiotic used to treat serious infections caused by multidrug-resistant Gram-negative bacteria. It works by inhibiting protein synthesis in bacteria. Common indications include suspected or proven late-onset neonatal sepsis and infections caused by susceptible Gram-negative organisms resistant to other antibiotics. Side effects include kidney damage, hearing loss, numbness, tingling, muscle twitching or seizures. Nurses should assess for signs of infection, ensure proper hydration, instruct patients on completing the full course of medication and reporting side effects.
Amikacin is an aminoglycoside antibiotic used to treat serious infections caused by multidrug-resistant Gram-negative bacteria. It works by inhibiting protein synthesis in bacteria. Common indications include suspected or proven late-onset neonatal sepsis and infections caused by susceptible Gram-negative organisms resistant to other antibiotics. Side effects include kidney damage, hearing loss, numbness, tingling, muscle twitching or seizures. Nurses should assess for signs of infection, ensure proper hydration, instruct patients on completing the full course of medication and reporting side effects.
Amikacin is an aminoglycoside antibiotic used to treat serious infections caused by multidrug-resistant Gram-negative bacteria. It works by inhibiting protein synthesis in bacteria. Common indications include suspected or proven late-onset neonatal sepsis and infections caused by susceptible Gram-negative organisms resistant to other antibiotics. Side effects include kidney damage, hearing loss, numbness, tingling, muscle twitching or seizures. Nurses should assess for signs of infection, ensure proper hydration, instruct patients on completing the full course of medication and reporting side effects.
Generic name: Amikacin is most Indications: Kidney damage and hearing Always wash hands Amikacin often used for Suspected or proven late-onset loss are the most important thoroughly and disinfect treating severe, neonatal sepsis. effects. to help prevent the Brand name: Amicin hospital-acquired Treatment of serious infections due spread of infection. Use infections with to susceptible strains of Gram Numbness, skin tingling, universal precautions or Classification: multidrug-resistant negative bacilli resistant to other muscle twitching, or seizures. isolation procedures as Aminoglycosides Gram-negative aminoglycosides. indicated for specific bacteria. Treatment of serious gram-negative patients. Dosage: Inhibits protein bacillary infections and infections 15mg/kg/day synthesis in bacteria caused by staphylococci when at level of 30S penicillins or other less toxic drugs Assess patient Frequency: QD q8- ribosome. are contraindicated. for signs and 12hr symptoms of Therapeutic Effects: Contraindications: Hypersensitivity infection prior to Route: IV/IM Bactericidal action. to amikacin/other aminoglycosides. and throughout therapy. Spectrum: Most 1. Extreme caution in neonates with Instruct patient aminoglycosides renal dysfunction. to continue notable for activity taking against P. 1. Most parenteral products medication aeruginosa, contains bisulfides and around the clock Klebsiella should be avoided in until finished pneumoniae, E. patients with known completely, even coli, Proteus, tolerance. Products if feeling better. Serratia, containing benzyl alcohol Keep patient Acinetobacter, should be avoided in hydrated during Staphylococcus neonates. therapy. aureus. In treatment Instruct patient 2. Use cautiously in: Renal of enterococcal to report signs of impairment (dose infections, synergy adjustments necessary; with a penicillin is hypersensitivity. required. blood level monitoring useful in preventing ototoxicity and nephrotoxicity); Hearing impairment; Pedi: Neonates have increased risk of neuromuscular blockade; cautious use due to difficulty in assessing auditory and vestibular function and immature renal function.